Well, well, well. Now, UHC requires a patient fail 3 atypicals, AND Wellbutrin, AND then they must submit the patient's medical records to prove they failed the 4 drugs! The idiots at Otsuka went from at least getting SOME revenue from UHC, down to $0! This formulary also applies to AARP drug coverage! So, what is Lundbeck going to do with our quotas to make up for this mess that we had nothing to do with? Make it right Lundbeck!!!!
HaHa! Make it right Lundbeck - that's a joke. They will cut expenses anyway they can and especially if it means they don't have to pay bonuses to those who make the money for this company. Wondering if the layoffs will come this fall of later? The only way that Rexulti can meet the goals is if they give it away
Kare has 5 million in options riding on you finding it elsewhere. Consider your forfeiture of bonus his contribution to his stellar stock performance so that the company is able to push that lost revenue back into the annual statement come October. UHC areas can pretty much just check boxes and assume your paycheck is your bonus. You might as well just look good on the spreadsheet being that the sales will be below and with their multiplier of insult grid where a few percent below equates to 10-20% more in reduction in pay... why bother.
The loss of UHC is huge. I started 7/1/17. Lundbeck knew before then what was going on, and still included prescriber data for UHC in our quotas. Totally unethical.
they knew it was likely going to get dropped but the big picture they don't care, they will let the little people on the street figure out where they will get that business from.
They knew well in advance that UHC had nailed Rexulti. As far as them adjusting out the UHC prescriber data, it will never happen. You will be held accountable for business that will be totally impossible to obtain. But what the hell, aren't we "building the plane as we fly?" Unbelievable!
US home office likely gets rewarded when the sales reps bonuses are limited. I'm guessing the bonus to sales ratio has dropped like a rock over past 2 years, even though US makes all the company's money.
This crap is getting real old, fast. Unreasonable quotas, 8 calls a day for a specialty sales force, meetings for no reason, endless spreadsheets, and endless field rides with managers that are useless in increasing sales! Then we lose UHC and we are STILL responsible for the sales of UHC prescribers! Yeah, this is getting real, real old.
On the Takeda Cafepharma thread they are reporting that they were told at a meeting that Trintellix will be BLOCKED on UHC on 1/1/18!!!!!! They know it now and they will love it in our quota just like Rexulti! Can't get much more unethical than this! We will have to fake our smiles at the Fall meeting, and the debacle in Vegas in February!
